Accredo by Evernorth

Accredo’s Oncology Therapeutic Resource Center® (TRC) goes beyond the prescription to provide comprehensive care for cancer patients. We offer personalized support programs and seamless therapy distribution, addressing social determinants of health (SDoH) by offering nutritional support and other vital resources to help improve overall patient well-being. Learn more in our latest white paper: https://bit.ly/48X0teu #OncologyTRC #TherapeuticResourceCenter #SpecialtyPharmacy

We’re excited to announce that Accredo specialty pharmacy successfully delivered the first shipment and treatment of ZOLGENSMA in Hawaii! Although ZOLGENSMA has been available since 2019, this marks the first time it has been administered in Hawaii, following the inclusion of spinal muscular atrophy (SMA) in newborn screenings across all 50 states as of January 1, 2024. This milestone brings new hope to families affected by SMA, and we’re proud to play a role in ensuring timely access to this life-changing therapy. Read the full story here: https://bit.ly/3YV7ibR #SpecialtyPharmacy #TherapeuticResourceCenter #TRC #SMA #SpinalMuscularAtrophy

We combine individualized support from our Oncology Therapeutic Resource Center with the power of our infrastructure to help manufacturers in ways smaller pharmacies can’t. Dive into the details in our latest whitepaper: https://bit.ly/48X0teu #OncologyTRC #SpecialtyPharmacy

November is Pulmonary Arterial Hypertension Awareness Month, and at Accredo, we’re dedicated to supporting patients living with this serious and often difficult to diagnose condition. Pulmonary arterial hypertension (PAH) affects the arteries in the lungs and heart, making early detection and treatment essential. Through our specialized Pulmonary Arterial Hypertension TRC, we provide personalized care, helping patients access vital therapies and navigate their treatment plans with expert guidance. Join us this month in raising awareness about PAH and the importance of early detection and treatment for better patient outcomes. https://lnkd.in/ez9W5uXE #PAH #SpecialtyPharmacy #PulmonaryArterialHypertension

November is Alpha-1 Awareness Month, and this year’s theme is “The Power to Connect”. We recognize the importance of building connections – whether it’s with patients and caregivers or providing access to vital therapies for those with Alpha-1 antitrypsin deficiency. Our APC and ICC Therapeutic Resource Centers® are proud to stand with the Alpha-1 community, providing specialized care for Alpha-1 patients. Learn more about how we support Alpha-1 patients: https://bit.ly/3NIkHPr #Alpha1AwarenessMonth #SpecialtyPharmacy Alpha-1 Foundation

Accredo's latest research highlights the power of combining our Therapeutic Resource Center (TRC) model with motivational interviewing to improve medication adherence. In a study of 41,000 patients across 300 disease states, patients receiving this layered approach showed an impressive 18% increase in adherence compared to controls. This demonstrates how personalized specialty pharmacy care and expert support can lead to better outcomes for patients managing complex conditions. Read the full article to learn more about these exciting findings: https://bit.ly/3NLqMdY #SpecialtyPharmacy #TRC #TherapeuticResourceCenter

⭐ We're at the 52nd Annual Convention of the Sickle Cell Disease Association of America, Inc. — National this week in Atlanta!⭐ Accredo is proud to stand with and support individuals living with sickle cell disease and their caregivers through comprehensive specialty pharmacy services designed to improve access, understanding, and adherence to therapies. Plus, we're unveiling the expansion of our Junior Care Force program filled with valuable resources for the sickle cell community. Visit JuniorCareForce.com or stop by our booth to learn more! #SCD #sicklecelldisease #SpecialtyPharmacy #TRC #TherapeuticResourceCenter

Join us in recognizing National Pharmacy Week, where we celebrate the incredible contributions of pharmacists and pharmacy technicians in patient care. Their expertise and dedication make a difference in the lives of countless patients' health care journey. #NationalPharmacyWeek #SpecialtyPharmacy

✔️ Our Rare Disease Therapeutic Resource Center®️ (TRC) offers more than clinical ability—it provides specialty manufacturers with valuable near real-time data and analytics capabilities through the Pharma Hub Portal. This powerful platform delivers insights into therapy patterns, patient adherence, and real-world outcomes, helping manufacturers refine therapy distribution and support patient journeys more effectively. By using these data-driven solutions, we empower better decision-making and enhance patient care for complex rare conditions. Read our latest insights article for more: https://bit.ly/3Ypc56m #RareDiseaseTRC #DataandAnalytics #PharmaHubPortal #SpecialtyPharmacy

We're at AMCP’s Nexus 2024 in Las Vegas this week! And thrilled to announce that our research on the Adherence Course Correct program has been selected for a poster presentation. The study, conducted across all Accredo’s Therapeutic Resource Centers® (TRCs), includes over 40,000 patients and shows significant improvements in medication adherence across the entire population. To learn more about our unique TRC model and how it helps drive medication adherence, stop by Express Scripts by Evernorth's booth number 523. And be sure to check out our poster, number Z1 located in the poster hall. Aren’t able to make it? You can access all our research posters here: https://bit.ly/48o4BUJ #AMCPNexus24 #MedicationAdherence #SpecialtyPharmacy